Simon Fraser University
Engaging the World

Recognizes an outstanding contribution to health services and policy research, policy and/or care delivery in Canada.

The EU Joint Programme - Neurodegenerative Disease Research (JPND) was established to better coordinate research efforts across countries and disciplines to find causes, develop cures, and identify better ways to care for people with neurodegenerative diseases more rapidly. The goal of this joint transnational call is to promote research aiming at the development of novel and the advanced use of existing cutting-edge imaging and brain stimulation technologies related to neurodegenerative diseases.

The Project Grant Program is designed to capture ideas with the greatest potential to advance health-related fundamental or applied knowledge, health research, health care, health systems, and/or health outcomes.

Type 1 diabetes (T1D) is an autoimmune disease that occurs when the body’s immune system attacks and destroys the insulin-producing beta cells in the pancreas. Over the past two decades, studies of islet transplantation have shown that this procedure can lead to insulin independence, normoglycemia and elimination of hypoglycemia in people with T1D who experience severe hypoglycemia or hypoglycemia unawareness

ICS Travel Awards support students, postdoctoral fellows, new investigators and knowledge users to present their own research at national and international meetings and/or conferences.

The Health System Impact Fellowship provides highly-qualified individuals with a doctorate degree in health services and policy research, or related fields, a unique opportunity to apply their research and analytic talents to critical challenges in health system and related organizations outside of the traditional scholarly setting (e.g., public, private for-profit, not-for-profit, and Indigenous health organizations that are not universities or research-focused institutes), and to develop professional experience, new skills, and networks.

This funding opportunity will support a Network to generate new knowledge to improve diagnosis and treatment of ME disease in Canada.

The Stars Career Development award supports early-career/mid-career investigators in firmly establishing their careers in the area of arthritis research.

The 'Network of European Funding for Neuroscience Research' (NEURON) was established under the ERA-NET scheme of the European Commission. The aim of ERA-NET NEURON is to coordinate and optimize research efforts and funding programmes of its partner countries in the fields of disease related neuroscience. CIHR and the NEURON funding organizations particularly wish to promote multi-disciplinary work and translational research proposals that combine basic and clinical approaches.

This program supports outstanding new investigators as they develop their careers as independent research scientists or clinician scientists to undertake high-quality cancer research, while in close collaboration and mentorship with established TFRI or CIHR-ICR-funded research teams

The Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and informal caregivers, provincial health authorities, academic health centres, charities, philanthropic organizations, private sector, etc.) dedicated to the integration of research into care.

The EU Joint Programme - Neurodegenerative Disease Research (JPND) was established to better coordinate research efforts across countries and disciplines to find causes, develop cures, and identify better ways to care for people with neurodegenerative diseases more rapidly. The goal of this joint transnational call is to promote research aiming at the development of novel and the advanced use of existing cutting-edge imaging and brain stimulation technologies related to neurodegenerative diseases.

This funding opportunity supports the creation of six network in the areas of musculoskeletal (MSK) rehabilitation, muscular dystrophy, skin health, concussion and youth mental health.

The goal of the CIHR-ICRH/CAAIF/AZ Canada/AllerGen Emerging Researcher Awards in Allergic Asthma is to enable Canadian allergists, clinical immunologists, MD clinician scientists, and basic scientists working in translational research to pursue academic research in allergic asthma.

This funding opportunity supports the development and testing of innovative methodologies/designs of innovative clinical trials (iCT) that is integrated with the principles of Strategy for Patient-Oriented Research (SPOR).

This catalyst grant supports research to expand current evidence and understanding of disease prevention that will lead to future intervention studies.

This opportunity is to support the establishment of a multidisciplinary platform with the research expertise to identify best practices for studying sex and age as biological variables in basic science, provide training, and promote these methods and services.

This opportunity is to support the establishment of a multidisciplinary platform with the research expertise to identify best practices for studying sex and age as biological variables in basic science, provide training, and promote these methods and services.

Honours excellence in health research and its translation into benefits for Canadians. These prizes, worth $100,000, are awarded every two years (with competitions closing in even-numbered years). These are institutional nominations;

The CIHR HIV/AIDS Community-Based Research (CBR) Program is one of four research funding areas of the CIHR HIV/AIDS Research Initiative. The CIHR HIV/AIDS Research Initiative is responsible for the research components of the major Government of Canada initiative in HIV/AIDS, namely the Federal Initiative to Address HIV/AIDS in Canada (FI).

The aim of the Catalyst Grant component of the CBR program is to provide seed money to support HIV/AIDS CBR research activities which represent a first step towards the pursuit of more comprehensive funding opportunities (e.g., operating grants).

Recognizes exceptional contributions in the area of population and public health research.